Literature DB >> 1375968

Pseudomonas cepacia--more than a harmless commensal?

.   

Abstract

Entities:  

Mesh:

Year:  1992        PMID: 1375968

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Epidemiology of pulmonary colonization with Burkholderia cepacia in cystic fibrosis patients. The French Observatoire Burkholderia cepacia Study Group.

Authors:  C Segonds; G Chabanon; G Couetdic; Y Michel-Briand; E Bingen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-10       Impact factor: 3.267

2.  Burkholderia (Pseudomonas) cepacia as a cause of brain abscesses secondary to chronic suppurative otitis media.

Authors:  R Hobson; I Gould; J Govan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-10       Impact factor: 3.267

3.  Aerobic Gram-negative Bacillary Pneumonia.

Authors:  Stephen Parodi; Matthew Bidwell Goetz
Journal:  Curr Infect Dis Rep       Date:  2002-06       Impact factor: 3.725

4.  Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes.

Authors:  S M Zughaier; H C Ryley; S K Jackson
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

5.  Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis.

Authors:  P W Whitby; H L Dick; P W Campbell; D E Tullis; A Matlow; T L Stull
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

6.  Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission.

Authors:  D L Smith; L B Gumery; E G Smith; D E Stableforth; M E Kaufmann; T L Pitt
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

7.  A melanin pigment purified from an epidemic strain of Burkholderia cepacia attenuates monocyte respiratory burst activity by scavenging superoxide anion.

Authors:  S M Zughaier; H C Ryley; S K Jackson
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

8.  Clinical outcome after acquisition of Burkholderia cepacia in patients with cystic fibrosis.

Authors:  M McCloskey; J McCaughan; A O Redmond; J S Elborn
Journal:  Ir J Med Sci       Date:  2001 Jan-Mar       Impact factor: 2.089

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.